Enterprise Value

-3.929M

Cash

6.664M

Avg Qtr Burn

-2.346M

Short % of Float

2.11%

Insider Ownership

9.26%

Institutional Own.

2.44%

Qtr Updated

09/30/23


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date

Approved

Quarterly sales

Approved

Quarterly sales

DPI-221 Details
Benign prostatic hyperplasia (BPH)

Phase 1

Update

DPI-125 Details
Opioid use disorder

Phase 1

Update

APC-410 (tempol) Details
Acute respiratory distress syndrome, Inflammatory disease, COVID-19

Failed

Discontinued

APC-400 (tempol) Details
Radiation Dermatitis

Failed

Discontinued